特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

喘息:世界の治験動向

Asthma Global Clinical Trials Review, H2, 2019

発行 GlobalData 商品コード 321697
出版日 ページ情報 英文 2349 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
喘息:世界の治験動向 Asthma Global Clinical Trials Review, H2, 2019
出版日: 2019年12月03日 ページ情報: 英文 2349 Pages
概要

当レポートでは、喘息治療薬に関する治験の最新動向について分析しており、主要7カ国 (G7) および新興7カ国 (E7) における治験件数と、被験者数、有望なスポンサー、治験に携わっている主な企業や機関、有望な薬剤の情報をまとめています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:呼吸器系疾患治療薬の治験における喘息の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:呼吸器系疾患治療薬の治験における喘息の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

喘息治療薬の治験に携わっている主要企業

有望な薬剤

治験プロファイルの概要

付録

図表

List of Tables

  • Asthma Therapeutics, Global, Clinical Trials by Region, 2019* 8
  • Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
  • Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
  • Asthma Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
  • Asthma Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
  • Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
  • Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
  • Proportion of Asthma to Respiratory Clinical Trials, G7 Countries (%), 2019* 17
  • Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
  • Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
  • Proportion of Asthma to Respiratory Clinical Trials, E7 Countries (%), 2019* 20
  • Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
  • Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
  • Asthma Therapeutics, Global, Clinical Trials by Phase, 2019* 23
  • Asthma Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 24
  • Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
  • Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
  • Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
  • Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 28
  • Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 30
  • Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
  • Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32

List of Figures

  • Asthma Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
  • Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
  • Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
  • Asthma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
  • Asthma Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
  • Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
  • Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
  • Proportion of Asthma to Respiratory Clinical Trials, G7 Countries (%), 2019* 17
  • Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
  • Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
  • Proportion of Asthma to Respiratory Clinical Trials, E7 Countries (%), 2019* 20
  • Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
  • Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
  • Asthma Therapeutics, Global, Clinical Trials by Phase (%), 2019* 23
  • Asthma Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 24
  • Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
  • Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
  • Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
  • Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 28
  • Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 29
  • Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
  • Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32
  • GlobalData Methodology 2435
目次
Product Code: GDHC5159CTIDB

GlobalData's clinical trial report, "Asthma Global Clinical Trials Review, H2, 2019" provides an overview of Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13
  • Top Countries Contributing to Clinical Trials in North America 14
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
  • Top Five Countries Contributing to Clinical Trials in Central and South America 16
  • Clinical Trials by G7 Countries: Proportion of Asthma to Respiratory Clinical Trials 17
  • Clinical Trials by Phase in G7 Countries 18
  • Clinical Trials in G7 Countries by Trial Status 19
  • Clinical Trials by E7 Countries: Proportion of Asthma to Respiratory Clinical Trials 20
  • Clinical Trials by Phase in E7 Countries 21
  • Clinical Trials in E7 Countries by Trial Status 22
  • Clinical Trials by Phase 23
  • In Progress Trials by Phase 24
  • Clinical Trials by Trial Status 25
  • Clinical Trials by End Point Status 26
  • Subjects Recruited Over a Period of Time 27
  • Clinical Trials by Sponsor Type 28
  • Prominent Sponsors 29
  • Top Companies Participating in Asthma Therapeutics Clinical Trials 31
  • Prominent Drugs 32
  • Latest Clinical Trials News on Asthma 33
  • Nov 26, 2019: AB Science will host a live webcast on masitinib in severe asthma on December 2, 2019 33
  • Nov 08, 2019: Gossamer announces data presentations at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting 2019 33
  • Nov 07, 2019: AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma 33
  • Oct 16, 2019: Grad student researches new drug to combat asthma 34
  • Oct 01, 2019: Nucala minimises exacerbations in eosinophilic asthma patients 35
  • Oct 01, 2019: Sosei Heptares notes the announcement of positive results from phase III IRIDIUM study of inhaled combination QVM149 in patients with uncontrolled asthma 35
  • Oct 01, 2019: Single-Inhaler Extrafine Triple Therapy of Inhaled Corticosteroid, Long-Acting B2-Agonist and Long-Acting Muscarinic Antagonist Therapy Improves Lung Function and Reduces Asthma Exacerbations 36
  • Sep 30, 2019: Novartis announces positive results from Phase III PALLADIUM study of inhaled combination QMF149 in patients with uncontrolled asthma 36
  • Sep 30, 2019: Novartis announces positive results from Phase III IRIDIUM study of inhaled combination QVM149 in patients with uncontrolled asthma 37
  • Sep 26, 2019: Pieris Pharmaceuticals and AstraZeneca present multiple ascending dose phase 1b data for inhaled IL4-Ra Antagonist AZD1402/PRS-060 at the 2019 European Respiratory Society International Congress 39
  • Sep 23, 2019: GlaxoSmithKline to present on Mepolizumab at ERS 2019 39
  • Sep 09, 2019: Theravance Biopharma reports positive results from phase 1 clinical trial of TD-8236, an investigational, lung-selective, inhaled Pan-Janus Kinase (JAK) inhibitor for inflammatory lung diseases 40
  • Clinical Trial Profile Snapshots 42

Appendix 2434

  • Abbreviations 2434
  • Definitions 2434
  • Research Methodology 2435
  • Secondary Research 2435
  • About GlobalData 2436
  • Contact Us 2436
  • Source 2437